Presbyopia News

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Julia Williams of Visus Therapeutics discusses positive results from the phase 3 BRIO-I clinical trial investigating Brimochol PF for presbyopia treatment.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Mitchell A. Jackson, MD, discusses the laser scleral microporation device with real-time OCT imaging.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, George O. Waring IV, MD, FACS, reports positive outcomes for patients with cataracts who were implanted with a combination of two different presbyopia-correcting IOLs.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, AnnMarie Hipsley, DPT, PhD, and Alex Lopez of Ace Vision Group provide an update on the development of the VisioLite ophthalmic laser for presbyopia.

The FDA approved Qlosi, a low-dose, preservative-free eye drop for the treatment of presbyopia in adults, according to a press release from Orasis Pharmaceuticals.

The decision of which type of IOL to implant in a patient is a multistep process in my practice.

VIENNA — In this Healio Video Perspective from the ESCRS meeting, Luca Gualdi, MD, speaks about the latest advances in laser scleral microporation.

Laser scleral microporation is a unique therapeutic solution for presbyopia that goes back to basics, rejuvenating the eye and restoring the natural dynamic mechanism of accommodation and disaccommodation.

VIENNA — The Duet procedure, in which a monofocal or monofocal toric IOL is implanted into the capsular bag and an additive trifocal IOL is implanted into the sulcus, showed stable long-term outcomes and good rotational stability.

VIENNA — In this Healio Video Perspective from the ESCRS meeting, Robert Ang, MD, shares his results with laser scleral microporation for the treatment of presbyopia.